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Background: The predictive value of resting heart rate (RHR) in asymptomatic aortic stenosis (AS) is not well described.
Methods: Patients with available RHR as detected by annual in-study 12-lead ECGs in the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) 
study of asymptomatic mild-to-moderate AS. Endpoints in this study were cardiovascular (CV) and all-cause mortality. Event rate ratios according to 
RHR ≥80 min-1 was investigated by Cox-regression models treating RHR as a fixed and time-varying covariate.
Results: 1,563 patients followed for a mean of 4.3 years (6,751 years of follow-up). Proportion of subjects dying from CV (n=75) and all-cause 
mortality (n=151) were 4.1% vs. 10.7% and 8.6% vs. 18.5% in those with a baseline RHR <80 min-1 vs. ≥80 min-1, respectively. Adjusted by 
randomized treatment, age, sex, atrial fibrillation, β-blockade, left ventricular (LV) mass and stroke volume, risk of CV and all-cause mortality was 
2.0-fold (95% CI, 1.1 to 3.7) and 1.8-fold (95% CI, 1.1 to 2.9, both p<0.05) greater in subjects with baseline RHR ≥80 min-1, respectively. Updating 
the multivariable analyses with time-varying LV mass and stroke volume, time-varying RHR ≥80 min-1 related to 2.5-fold (95% CI, 1.4 to 4.3) and 
2.3-fold (95% CI, 1.6 to 3.4, both p<0.01) greater risk of CV (Figure) and all-cause mortality, respectively.
Conclusion: RHR provides independent predictive information of CV and all-cause mortality in asymptomatic AS. Temporal assessment further 
improves prognostic performance.
 
